Product NDC: | 50102-100 |
Proprietary Name: | Norethindrone |
Non Proprietary Name: | Norethindrone |
Active Ingredient(s): | .35 mg/1 & nbsp; Norethindrone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50102-100 |
Labeler Name: | Afaxys Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200980 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130624 |
Package NDC: | 50102-100-48 |
Package Description: | 48 CARTON in 1 CASE (50102-100-48) > 1 BLISTER PACK in 1 CARTON > 28 TABLET in 1 BLISTER PACK |
NDC Code | 50102-100-48 |
Proprietary Name | Norethindrone |
Package Description | 48 CARTON in 1 CASE (50102-100-48) > 1 BLISTER PACK in 1 CARTON > 28 TABLET in 1 BLISTER PACK |
Product NDC | 50102-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Norethindrone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130624 |
Marketing Category Name | ANDA |
Labeler Name | Afaxys Inc. |
Substance Name | NORETHINDRONE |
Strength Number | .35 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |